David John Irwin MD

Dr. Irwin is an attending cognitive neurologist at the Frontotemporal dementia center at the University of Pennsylvania. He received his MD from Drexel University College of Medicine in Philadelphia where he completed his residency and chief residency training in Neurology. Dr. Irwin completed his postdoctoral clinical and research fellowship in the Center for Neurodegenerative Disease Research and the Penn Frontotemporal Degeneration Center.

Dr. Irwin has an interest in young onset dementia and his research focuses on the interface of clinical symptoms and underlying neuropathology in neurodegenerative disease. The purpose of this approach is to better identify clinically, pathologically and genetically homogeneous patient populations for inclusion into clinical trials to efficiently study emerging disease-modifying treatments that target the pathogenic proteins specific for each neuropathological subtype of disease (e.g. FTLD-associated with tau or TDP-43 protein inclusions).